Author

Dimitrios Mathios

Assistant Professor of Neurosurgery, Washington University in St Louis - Cited by 3,335 - Neurosurgery

Biography

Dr.  Dimitrios Mathios is currently working in Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, USA. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work. 
Title
Cited by
Year
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
AL Hung, R Maxwell, D Theodros, Z Belcaid, D Mathios, AS Luksik, E Kim, ...Oncoimmunology 7 (8), e1466769, 2018201
244
2018
Detection and characterization of lung cancer using cell-free DNA fragmentomes
D Mathios, JS Johansen, S Cristiano, JE Medina, J Phallen, KR Larsen, ...Nature communications 12 (1), 5060, 2021202
132
2021
Expression of LAG‐3 and efficacy of combination treatment with anti‐LAG‐3 and anti‐PD‐1 monoclonal antibodies in glioblastoma
S Harris‐Bookman, D Mathios, AM Martin, Y Xia, E Kim, H Xu, Z Belcaid, ...International journal of cancer 143 (12), 3201-3208, 2018201
100
2018
Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment
A Wu, R Maxwell, Y Xia, P Cardarelli, M Oyasu, Z Belcaid, E Kim, A Hung, ...Journal of neuro-oncology 143, 241-249, 2019201
96
2019
Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system
R Maxwell, AS Luksik, T Garzon-Muvdi, AL Hung, ES Kim, A Wu, Y Xia, ...Oncoimmunology 7 (12), e1500108, 2018201
60
2018
Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy
Z Belcaid, C Berrevoets, J Choi, E Van Beelen, E Stavrakaki, T Pierson, ...Neuro-oncology advances 2 (1), vdaa011, 2020202
30
2020
Genotype-phenotype correlations in neurofibromatosis and their potential clinical use
C Bettegowda, M Upadhayaya, DG Evans, AR Kim, D Mathios, ...Neurology 97 (7 Supplement 1), S91-S98, 2021202
22
2021
Genome‐wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types
D Mathios, T Hwang, Y Xia, J Phallen, Y Rui, AP See, R Maxwell, ...International journal of cancer 145 (12), 3425-3435, 2019201
17
2019
Detecting liver cancer using cell-free DNA fragmentomes
ZH Foda, AV Annapragada, K Boyapati, DC Bruhm, NA Vulpescu, ...Cancer discovery (3), 616-631, 2023202
13
2023
Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced somatic mutation rates in survival outliers of glioblastoma
T Hwang, D Mathios, KL McDonald, I Daris, SH Park, PC Burger, S Kim, ...Acta neuropathologica communications 7 (1), 1-12, 2019201
13
2019
Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma
J Choi, R Medikonda, L Saleh, T Kim, A Pant, S Srivastava, YH Kim, ...Oncoimmunology 10 (1), 1956142, 2021202
13
2021
Synergy between glutamate modulation and anti–programmed cell death protein 1 immunotherapy for glioblastoma
R Medikonda, J Choi, A Pant, L Saleh, D Routkevitch, L Tong, Z Belcaid, ...Journal of neurosurgery 136 (2), 379-3, 2021202
8
2021
Combination of immunotherapy with local chemotherapy for the treatment of malignancies
D Mathios, B Tyler, D Pardoll, H Brem, M LimUS Patent 10,864,180, 2020202
7
2020
New prospects for molecular targets for chordomas
MZ Ozair, PP Shah, D Mathios, M Lim, NS MossNeurosurgery Clinics 31 (2), 289-300, 2020202
7
2020
Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic
ML Stone, KB Chiappinelli, H Li, LM Murphy, ME Travers, MJ Topper, ...Proceedings of the National Academy of Sciences 115 (37), E8583-E858, 2018201
4
2018
Early detection of lung cancer using cfDNA fragmentation.
D Mathios, JS Johansen, S Cristiano, J Medina, J Phallen, ...Journal of Clinical Oncology 9 (15_suppl), 8519-8519, 2021202
3
2021
Circulating biomarkers in glioblastoma: ready for prime time?
D Mathios, J PhallenThe Cancer Journal 27 (5), 404-409, 2021202
3
2021
Synthesizing molecular and immune characteristics to move beyond WHO grade in meningiomas: a focused review
NV Kannapadi, PP Shah, D Mathios, CM JacksonFrontiers in oncology 12, 892004, 2022202
3
2022
Emerging technologies for non-invasive monitoring of treatment response to immunotherapy for brain tumors
D Mathios, S Srivastava, T Kim, C Bettegowda, M LimNeuromolecular medicine 24 (2), 74-87, 2022202
3
2022
Why is immunotherapy for glioblastoma “Lag”-ging
D Mathios, M LimOncotarget 10 (1), 18, 01901
2
2019

Referred From: https://scholar.google.co.in/citations?hl=en&user=vJ0Qi6oAAAAJ

Cited by
Citations 3335
h-index 21
i10-index 28
Recommended Journals
Open Access Journals